145 related news articles for Inflammation

A/Prof Lawlor leads the Cell Death and Inflammatory Signalling Group that investigates the intricate links between cell death and inflammation and how these processes impact various inflammatory and infectious diseases. …  Read more

Hudson Institute’s Director and CEO, Professor Elizabeth Hartland, is among the recipients of the Order of Australia in the King’s Birthday Honours list, for services to medical research.…  Read more

Hudson Institute researcher Professor Seth Masters, working with colleagues at China’s Guangzhou Women and Children’s Medical Center, has identified a specific genetic variant which contributes to the development of childhood-onset lupus.…  Read more

When unborn babies suffer a stroke, the potential damage can be life-long, so Hudson Institute of Medical Research is aiming to change that using the stem cells found in umbilical cord blood (UCB).…  Read more

Hudson Institute’s resident flu guru, Associate Professor Michelle Tate, answers all your questions heading into this flu season.…  Read more

Hudson Institute’s reputation as a leader in inflammation research has been boosted by the appointment of two specialists in the field.…  Read more

Hudson Institute partner BiomeBank has secured a multimillion-dollar Federal Government grant that will turbocharge the development and production of microbiome-based therapeutics.…  Read more

Hudson Institute of Medical Research today officially unveiled its world-first RNAte platform that could see vaccines and therapeutic treatments developed faster by being able to rapidly assess their potential inflammation side effects, right here in Victoria.…  Read more

A new treatment that controls the body’s response to influenza virus is shaping as the key to preventing dangerous lung inflammation and damage.…  Read more

Hudson Institute’s world leading inflammation programs enter a new era with the appointment of Professor Seth Masters to lead the Centre for Innate Immunity and Infectious Diseases (CiiiD).…  Read more

H. pylori – short for Helicobacter pylori – colonises the stomach and is known to be linked to the development of stomach cancer. It is estimated that over half of the world’s population is infected with H. pylori, making it one of the most common bacterial infections.…  Read more

When influenza (or flu) reaches the critical stage, there are no specific treatments available for patients. Now new research has identified a key to this sometimes fatal condition, and opened the door to possible cures.…  Read more

Inflammation is at the heart of numerous diseases and new research has found that the exact time an innate immune cell dies is crucial to the inflammatory process.…  Read more

A major systematic review of treatments for protecting the newborn brain from the negative effects of inflammation has found that earlier anti-inflammatory intervention is best, but it’s better late than never.…  Read more

A cancer drug could play an important role in limiting the damaging effects of lung disease inflammation in COVID-19 patients, thanks to new research at Hudson Institute.…  Read more

Latest research into the human microbiome begins to untangle how broccoli can alter healthy gut bacteria.…  Read more

Researchers are taking a new approach to a debilitating illness by looking for a microbiome-based cause of Inflammatory Bowel Disease (IBD).…  Read more

A new class of anti-inflammatory drug is opening a world of possibilities for treating everything from neurological diseases to cancers.…  Read more

The COVID-19 pandemic made RNA a topic of everyday discussion – suddenly, it was everywhere. For many Hudson Institute scientists, that meant an unprecedented level of interest in something they had spent many years studying. …  Read more

Most of us imagine evolution to be a slow process, with changes taking place within species over thousands of years. Associate Professor Jaclyn Pearson is not like most of us. …  Read more

It has long been recognised that inflammation can harm an unborn baby’s brain development, but exactly how it happens has been a mystery…until now.…  Read more

If you have ever wondered what happens to the bacteria living in the food you eat then here is an opportunity to find out!…  Read more

When it works as intended, the human gut is rarely given a thought – but that is rare luxury for the 130,000 Australians with inflammatory bowel disease (IBD), like Marisa…  Read more

The benefits of creatine are well known for helping with muscle performance, and now attention has turned to whether it can help mothers and babies have a safer birth.…  Read more

Exciting new treatments for unmet medical needs including ovarian cancer have been awarded significant funding from Australia’s national biotechnology incubator, CUREator.…  Read more

Last year respiratory syncytial virus (RSV) in infants and children shot up, causing record numbers of hospitalisations.  Respiratory virus expert, Associate Professor Michelle Tate share’s what you need to know about RSV in 2023.…  Read more

Influenza expert, A/Prof Michelle Tate shares everything that you need to know for the 2023 flu season, including who is most at risk. …  Read more

Six of the best early career researchers have been chosen to take part in the Hudson Institute 2023 Emerging Leaders Program. …  Read more

Hudson Institute research into treatments for severe influenza and pelvic organ prolapse have received funding in the Victorian Medical Research Acceleration grants 2023.…  Read more

Shining a light on how the lung microbiome in the first days of life can affect the immune system for years to come, Hudson Institute researchers have taken an important first step in an increasingly relevant field of medical study.…  Read more

A long-awaited treatment for a common cause of cancer is a big step closer thanks to Federal Government NHMRC funding – offering hope that naturally occurring nanoparticles will be the missing link for treating chronic liver disease.…  Read more

A biomedical team based at Hudson Institute has received sought-after funding to pursue new international interdisciplinary RNA research cooperation.…  Read more

The discovery of a new class of host-targeted therapy could give the medical profession a much-needed treatment option for serious flu infections.…  Read more

Keeping T cells active, but not too active, could be the key to new potential immune therapies, according to the latest research.…  Read more

It’s a disease in search of a remedy, but Hudson Institute researchers have identified a new pancreatitis treatment target, giving hope to sufferers worldwide.…  Read more

Two new candidates have been identified as crucial factors in maintaining good intestinal health.…  Read more

Hudson Institute researchers have featured prominently among the latest recipients of NHMRC Ideas Grants.…  Read more

A microbial mastermind and rock star scientist from Hudson Institute has today been announced as one of Australia’s newest Superstars of STEM.…  Read more

A leader in the fight against one of the world’s most urgent medical problems, beating antimicrobial resistance (AMR) has been granted $1.375 million over five years from a local philanthropist to progress her work.…  Read more

This is the time of year when we look back at what we have achieved and acknowledge the people who helped us make it happen. …  Read more

When baby Max arrived – early and in a hurry – no-one realised he would play a vital part in keeping other preterm babies healthy in the future.…  Read more

The long-term effects of newborn brain injuries are well known, so Professor Suzanne Miller’s dream is to be able to detect and treat those injuries in time to make a difference.…  Read more

This inflammatory condition affecting the digestive system can seriously impact people’s lives – so what is Crohn’s disease and how is it treated?…  Read more

A young Melbourne scientist will spend the next three years advancing exiting new mRNA research to unlock the secrets to how RNA triggers the immune system to fight infection.…  Read more

Hudson Institute’s Dr Samuel Forster has received a highly prestigious fellowship to advance his work using the bacteria of the human microbiome to treat Inflammatory bowel disease (IBD).…  Read more

Researchers are closer than ever to being able to turn off the actions of the immune system that damage the lungs – opening up the possibility of slowing emphysema development.…  Read more

When he was 11 years old, Associate Professor Michael Gantier had a close shave with death. Failing to recover after having his appendix removed, he was rushed to emergency surgery where doctors discovered he had sepsis.…  Read more

If an army marches on its stomach, as the old saying goes, then the US Department of Defense (DoD) is investing wisely in Australian upper gastrointestinal cancer research.…  Read more

It’s a disease that causes millions of deaths worldwide every year, but there are still large gaps in our understanding of what causes gastroenteritis.…  Read more

A naturally occurring molecule found in soy products could hold the clue to a new class of potent anti-inflammatory drugs, targeting diseases ranging from heart conditions to COVID-19.…  Read more

The world is in the midst of another global health crisis, one that existed before COVID-19 – antimicrobial resistance.…  Read more

Chronic or acute inflammation can contribute to a range of ailments – some potentially deadly – including stroke, respiratory and heart disease, cancer, arthritis, asthma, dementia, multiple sclerosis, and diabetes.…  Read more

Hudson Institute’s groundbreaking research into new anti-inflammatory treatments has attracted the support of the Victorian government, in recognition of its potential to treat COVID-19 and other infectious diseases.…  Read more

The enormous potential of RNA-based treatments for autoimmune diseases has been recognised by the Victorian government, with a new grant from the mRNA Victoria Research Acceleration Fund.…  Read more

A promising avenue of research into chronic lung disease treatment has hit a speed bump, with new research showing that 3D manufacturing mesenchymal stem cells (MSCs) may not be the panacea that was hoped.…  Read more

After two years of unusually low influenza infections due to social distancing, flu season 2022 is shaping up as a bad one for Australia. Influenza expert, Associate Professor Michelle Tate, answers some of the most frequently asked questions about flu and what we can expect in Australia this winter.…  Read more

Bacteria that cause weight loss and intestinal inflammation have been identified in the microbiome of mice used to study Inflammatory Bowel Disease (IBD).…  Read more

An international study that found a novel genetic cause of lupus owes much of its success to a single lab in Melbourne.…  Read more

For the first time the mechanism that spreads antimicrobial resistance inside the human gut has been identified in the lab.…  Read more

A new anti-viral drug to target the cause of viral lung infections and the infection itself could be a game-changer in treating severe influenza.…  Read more

It’s the essential physiological response that keeps you alive but can also kill you.…  Read more

A cell therapy could reduce inflammatory response in liver disease, offering hope to thousands of Australians suffering from the disease.…  Read more

RNA technology developed by Hudson Institute of Medical Research with the potential to limit inflammatory side-effects of RNA therapeutics such as mRNA vaccines, is the subject of a new licensing deal.…  Read more

Many human diseases, including autoimmune diseases such as arthritis or inflammatory bowel disease, are characterised by too much inflammation.
There has been a gap in producing new generations of potent anti-inflammatory therapeutics for these anti-inflammatory conditions.…  Read more

Hudson Institute has again been recognised as a leader in medical research with our CEO & Director appointed to the Council of the National Health and Medical Research Council (NHMRC).…  Read more

Hudson Institute’s expertise in established and emerging fields of medical research has been recognised, with Research Group Head Dr Minni (Minna-Liisa) Änkö added to mRNA Victoria’s Scientific Advisory Group (SAG).…  Read more

A study on how genes of the immune system influence the development of gastric (stomach) cancer has identified a key contributor, offering the potential for better prognosis and treatment of this deadly disease.…  Read more

A major research study has shed new light on an antibiotic-resistant bacteria with the potential to cause massive health issues in Australia and overseas.…  Read more

A paper published in the prestigious journal, Science Immunology, explores the idea that studying bats’ responses to SARS-CoV-2 may provide key insights into how and when to best use existing therapies for COVID-19, and to develop new treatments.…  Read more

Taking lessons learned studying coral reefs, a Melbourne researcher is taking a plunge into the microorganisms that inhabit our insides.…  Read more

RNA therapeutics comprise a rapidly expanding category of drugs that have the potential to revolutionise treatments for many diseases, including those currently deemed undruggable.…  Read more

Six Early Career Researchers have been chosen for the 2021 Hudson Institute Emerging Leaders program.…  Read more

Hudson Institute of Medical Research is progressing its genomic and inflammation research with the acquisition of an Illumina NextSeq 2000, a new sequencing system that provides unprecedented genomic capacity to study inflammatory diseases and microbial diversity.…  Read more

Rachel Botros has suffered from Crohn’s disease since she was a 14-year-old. The chronic condition interrupted her schooling and ability to live a typical teenage life. Her two siblings also have the disease. …  Read more

Hudson Institute of Medical Research and Monash University have received more than $1.6 million in funding from the Federal Government’s Medical Research Future Fund (MRFF) towards research investigating ways to prevent and treat silicosis.…  Read more

Leading virus scientist, Associate Professor Michelle Tate explains why new treatments are needed alongside vaccines.…  Read more

This discovery of the potential therapeutic benefits of a naturally occurring compound found in broccoli has earned two scientists a prestigious $10 000 award to progress their preeclampsia research.…  Read more

Crohn’s is an inflammatory disease which affects the gastrointestinal tract. It is incurable and usually chronic with periods of flare ups lasting from anywhere from a few days to a several months.…  Read more

Hudson Institute has been successful in the NHMRC Ideas Grant round. Our researchers have been awarded four NHMRC Ideas Grants, totalling almost $4.1 million.…  Read more

Hudson Institute scientists have paved the way to potentially test new treatments for chronic obstructive pulmonary disease (COPD) and emphysema, following a discovery of the molecular drivers of these lung diseases.…  Read more

Hudson Institute researchers have been awarded more than $2 million from the Australian Research Council Discovery Projects Grant round.…  Read more

In collaboration with colleagues at the Walter and Eliza Hall Institute (WEHI) and the University of Melbourne, Hudson Institute scientists have revealed how inflammation in motor neuron disease (MND) is caused,…  Read more

It is unknown how US President Donald Trump will respond to the experimental immunotherapy given to treat his COVID-19 infection, because the drug has not yet been tested and approved, says Hudson Institute Director and CEO, Professor Elizabeth Hartland.…  Read more

Hudson Institute scientists have discovered the key to how cells turn on inflammation and fight infection, providing the knowledge to potentially reduce or stop destructive inflammation in the future.…  Read more

Australia’s medical research sector will benefit from the appointment of Hudson Institute inflammation scientist Associate Professor Ashley Mansell to global firm Morningside BioPharma Advisory,…  Read more

Inflammation is at the core of life-threatening severe COVID-19 cases. More than 100 researchers at Hudson Institute investigate…  Read more

The first clinical trial of a potential COVID-19 treatment involving a discovery by Hudson Institute researchers received approval in September.…  Read more

Olive, 11 and her brother Will, 8 wanted to say a big thank you to their scientist heroes for all their hard work to improve people’s lives, including on COVID-19 research.…  Read more

My name is Michael Gantier and I am a scientist at Hudson Institute. My lab is working on a potential treatment for life-threatening COVID-19 symptoms, …  Read more

Crohn’s disease is an incurable inflammatory bowel disease (IBD) affecting more than 60,000 Australians, including children.…  Read more

More than 200,000 people have died from COVID-19 since January 2020. While Australia has been relatively spared from the onslaught of infections and deaths, our nation’s scientists need to be part of the global effort to address this pandemic.…  Read more

There is something unusual about the initial—or innate—immune response to COVID-19 compared to usual influenza patterns. …  Read more

Severe COVID-19 infection presents as excessive lung inflammation, involving the build-up of cells and fluid in the lungs. This phenomenon, known as ARDS, restricts breathing and causes damage to the lungs. Severely affected patients will need ventilator assistance in intensive care.…  Read more

Biotech company Noxopharm is seeking approval from the US FDA for a clinical trial in COVID-19 patients of an end-stage prostate cancer drug, following a discovery by Hudson Institute researchers that it could act as an anti-inflammatory.…  Read more

An existing cancer drug could potentially modify a severe hyper-inflammatory ‘storm’ associated with some conditions, which may include the COVID-19 virus, according to Hudson Institute researchers.…  Read more

Hudson Institute scientists have discovered how a molecule is transferred between damaged cells and healthy immune cells, which might cause toxic inflammation in a host of diseases.…  Read more

The discovery that the bladder isn’t sterile has opened up new avenues of treatment for urinary tract infections (UTI).…  Read more

Hudson Institute researchers provide new insights into how the IL-37 protein blocks inflammation—emphasising the potential for a novel treatment in the fight against a plethora of inflammatory diseases.…  Read more

New and improved treatments for many serious ailments could follow a prestigious $5 million NHMRC Synergy grant to a team led by Hudson Institute of Medical Research scientists.…  Read more

Hudson Institute has had outstanding success in the NHMRC Ideas Grant round.

Our researchers have been awarded nine NHMRC Ideas Grants, totalling almost $8.5 million and a success rate of 19.1 per cent.…  Read more

Six Early Career Researchers have been chosen for the inaugural Hudson Institute Emerging Leaders program.…  Read more

Dr Kate Lawlor has been awarded a prestigious ARC Future Fellowship to further her research into cell death.…  Read more

Our genetic material can predispose us to a number of diseases and conditions. Technologies to edit or change our genes are still in their infancy, so scientists are instead looking for ways to use treatments to stop genes that cause health conditions from being turned on.…  Read more

Volunteers are needed for a research project looking at whether the composition of the gut microbiome changes across the menstrual cycle.…  Read more

The introduction of faecal transplants has provided a new and welcome approach to treating difficult bacterial infections. However, following a patient death, there are questions over their future use. How can the risks surrounding transplants be removed to reap the benefits of this promising therapeutic treatment?…  Read more

Research has shown babies born vaginally have different gut bacteria (microbiome) than those delivered by caesarean.…  Read more

Hudson Institute is delighted to announce the success of our researchers in the new NHMRC Investigator Grant round.…  Read more

Scientists have discovered that the gut-infecting bacterium Clostridium difficile is evolving into two separate species, with one group highly adapted to spread in hospitals.…  Read more

A drug used in WW II to treat inflammation may hold the key to saving lives in the fight against flu deaths.…  Read more

Influenza expert Dr Michelle Tate answers frequently asked questions about the flu and addresses misconceptions that often come up in conversation during the winter months.…  Read more

More than 120 medical research scientists in the field of inflammation converged at Hudson Institute of Medical Research today to share knowledge and find solutions for patients across a broad range of diseases.…  Read more

The discovery of a human mutation that controls inflammation could lead to improved treatments for infectious diseases. Potentially, this could improve health outcomes worldwide for diseases such as bacterial infections, septic shock, or common colds and flu.…  Read more

Scientists working on the gut microbiome have discovered and isolated more than 100 completely new species of bacteria from healthy people’s intestines.…  Read more

Leading microbiome expert, Dr Sam Forster, in collaboration with researchers at EMBL’s European Bioinformatics Institute and the Wellcome Sanger Institute (UK) have identified almost 2000 bacterial species living in the human gut.…  Read more

A landmark Nature study that sheds light on how E.coli wreaks havoc on the body has earned Hudson Institute researcher, Dr Jaclyn Pearson, one of the nation’s top scientific awards. The National Association of Research Fellows (NARF) awarded Dr Pearson the 2018 Postdoctoral Investigator Award for her research that shows how some types of E.coli…  Read more

Hudson Institute has had excellent success in the recent NHMRC and ARC Grant rounds.…  Read more

Hudson Institute’s finest medical researchers will continue to push the boundaries in their field thanks to continued generous support from Mr Peter Fielding and the Fielding Foundation. This year, Research Group Heads, Associate Professor Claudia Nold (2019 Fielding Foundation Fellowship) and Dr Michael Gantier (2019 Fielding Innovation Award), were rewarded for their innovative scientific projects.…  Read more

Two promising young Hudson Institute researchers, Dr Cristina Giogha and Aidan Kashyap received highly sought after Victoria Fellowships, funded by the State Government of Victoria and delivered by veski.…  Read more

Hudson Institute has had outstanding success in the recent National Health and Medical Research Council (NHMRC) Fellowship and Development Grant announcements.…  Read more

Congratulations to the 2018 Hudson Institute Travel Awards recipients, who will attend international conferences and visiting laboratories to build invaluable knowledge in their area of research. The Awards (supported by donations from the Grisha Sklovsky Memorial Fund and Philip Wind Travel Fund) support six Hudson Institute Postdoctoral Fellows and PhD students to gain experience relevant…  Read more

The Hudson Institute Equity Travel Awards assists a staff member who has a career disruption to progress their research and career development. Dr Genevieve PepinCentre for Innate Immunity and Infectious DiseasesResearch Group: Nucleic Acids and Innate ImmunitySupervisor: Dr Michael Gantier The award will enable Genevieve to present her data at the International Cytokines and Interferon…  Read more

Cutting edge genomics has now shown the female bladder is home to a community of bacteria – similar to the gut microbiome – even in the absence of infection. The research could provide new urinary tract infection (UTI) treatments.…  Read more

Why do seasonal strains of influenza make many people sick yet cause relatively few deaths, while 40 per cent of people affected by strains of avian influenza, or ‘bird flu’, succumb to their infection? A discovery by Associate Professor Ashley Mansell could form a strategy to protect the world’s population from a potential global outbreak…  Read more

A world-first study has shown ‘length does matter’ when using small molecules called microRNAs as potential biomarkers to detect and predict cancer and inflammatory diseases. The study, published in the journal RNA, was led by Dr Michael Gantier and PhD student Ms Charlotte Nejad at Hudson Institute, together with collaborators from Monash University, Royal College…  Read more

Hudson Institute has had outstanding success in the recent NHMRC Project Grant round. In addition, our researchers have been awarded an NHMRC Partnership Grant, an NHMRC Development Grant, an ARC Discovery Grant and three NMHRC Fellowships.…  Read more

Dr Jaclyn Pearson from the Centre for Innate Immunity and Infectious Diseases has been named as a L’Oréal-UNESCO For Women in Science 2017 Australian Fellow. The prestigious fellowship recognises Dr Pearson’s contribution to science and will support her career progression. Read about what has inspired Dr Pearson and her work.…  Read more

There have been more than 2.5 times the number of laboratory confirmed cases of flu (160,000) in Australia compared with the same period last year. The effects of a bumper flu season are still being felt well into spring, with moderate levels of flu activity expected to linger into October. Around 800 people die from the…  Read more

Emerging leader in viral pathogenesis and immunology, Dr Michelle Tate has received a promotion to lead her own research group. Dr Tate’s research group, ‘Viral immunity and immunopathology’ will focus on the understanding the induction of hyperinflammation during an influenza virus infection. “My research aims to better understand the mechanisms that contribute to the induction…  Read more

Hudson Institute welcomes postdoctoral microbiology researcher, Dr Jaclyn Pearson, who joins the Centre for Innate Immunity and Infectious Diseases as Head of the Host-Pathogen Interactions Research Group. Dr Pearson joins the Institute from the Doherty Institute for Infection and Immunity, where she led research on pathogenic E. coli in the laboratory of Hudson Institute’s new…  Read more

A discovery by Melbourne researchers has solved a longstanding mystery of how viruses trigger protective immunity within our body. The research team demonstrated a protein called SIDT2 was crucial for cells to detect viral components in their environment, and initiate an immune response to reduce the virus’ spread. As well as being an important part…  Read more

New research by scientists at the Hudson Institute of Medical Research suggests that the immune response to a common childhood viral infection that causes gastroenteritis, could trigger type 1 diabetes in children with a specific genetic predisposition. Dr Anthony Sadler and his team uncovered the link, which may help to explain why some children develop…  Read more

Bella, a gorgeous, happy young girl who, sadly, suffers from a common chronic and life-threatening childhood disease, type 1 diabetes.…  Read more

The Fielding Foundation Fellowship 2017 has been jointly awarded to two outstanding immunology researchers at Hudson Institute, Dr Niamh Mangan, from the Centre for Innate Immunity and Infectious Diseases, and Associate Professor Marcel Nold, from The Ritchie Centre.…  Read more

Hudson Institute of Medical Research researchers have been awarded National Health and Medical Research Council Fellowships in the latest funding announcements.…  Read more

Hudson Institute researchers have been awarded more than $10 million in funding by the National Health and Medical Research Council (NHMRC).…  Read more

Melbourne researchers have shown that a century-old topical antiseptic used to treat wounds and ‘sleeping sickness’ in Australian soldiers in World War One could activate the immune system to protect against viral infection, and may prove key in the fight against antibiotic resistance.…  Read more

Melbourne researchers have identified a protein (follistatin) that could prevent damage to donated organs before and after transplantation, and potentially stop the body rejecting the…  Read more

A team of researchers at Hudson Institute of Medical Research have found that timely blocking of the body’s own immune response to infection from a severe or pathogenic strain of influenza could be vital in treating patients infected during a global pandemic.…  Read more

Researchers are optimistic that a recent breakthrough allowing growth of the majority of human gut bacteria in the lab will lead to the development of new therapies for human health, replacing the use of faecal transplants in treating certain gut infections.…  Read more

A group of students from the John Monash Science School experienced the future of science during a Discovery Tour at Hudson Institute of Medical Research to celebrate International Day of Immunology.…  Read more

Federal Member for Chisholm and former speaker, Anna Burke, and City of Monash Mayor, Cr Stefanie Perri, toured the Monash Health Translation Precinct’s (MHTP) new $84 million Translational Research Facility yesterday (Monday, February 15).…  Read more

Associate Professor Marcel Nold has been named the inaugural winner of the $50,000 Fielding Innovation Award for his work on cytokines, their signalling and role in suppressing inflammation.…  Read more

Inflammation is an important response to infection or injury, but needs to be carefully controlled as too much inflammation can cause conditions such as cancer, diabetes, heart disease and Alzheimer’s disease.…  Read more

Scientists who have discovered the mechanism of a protein that suppresses inflammation in the body, say the information could potentially be used to develop new drugs to control inflammation.…  Read more

The Australian Research Council has awarded leading scientist and biological engineer, Dr Michael Gantier, a 2014 Future Fellowship for his outstanding research at the MIMR-PHI Institute.…  Read more